Product correctly added to cart.

N-Cyclohexyl-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-amine
View 3D

Biosynth logo

N-Cyclohexyl-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-amine

CAS: 73029-73-9

Ref. 3D-FC44203

1mgDiscontinued
2mgDiscontinued
5mgDiscontinued
10mgDiscontinued
25mgDiscontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .


Product Information

Name:
N-Cyclohexyl-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-amine
Description:

Salinomycin sodium is a pharmacological agent that inhibits the intracellular activity of cyclic nucleotide phosphodiesterases (PDE) and blocks the hydrolysis of cAMP. Salinomycin sodium has been shown to cause membrane hyperpolarization, melanogenesis, and neuronal death. The mechanism of action for salinomycin sodium is not fully understood but it is believed that it may be due to its ability to inhibit ion channels or activate cation channels. This drug also has significant cytotoxicity against cancer cells and has been shown to inhibit the growth of bacteria such as Staphylococcus aureus and Mycobacterium tuberculosis.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
285.39 g/mol
Formula:
C16H23N5
Purity:
Min. 95%
InChI:
InChI=1S/C16H23N5/c1-11-10-15(18-14-7-5-4-6-8-14)19-16(17-11)21-13(3)9-12(2)20-21/h9-10,14H,4-8H2,1-3H3,(H,17,18,19)
InChI key:
InChIKey=USEMRPYUFJNFQN-UHFFFAOYSA-N
SMILES:
Cc1cc(NC2CCCCC2)nc(-n2nc(C)cc2C)n1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Inquiry about discontinued product: 3D-FC44203 N-Cyclohexyl-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-amine

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".